6-31542225-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000458640.5(DDX39B):c.-278G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.063 in 666,924 control chromosomes in the GnomAD database, including 1,647 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.075 ( 449 hom., cov: 33)
Exomes 𝑓: 0.060 ( 1198 hom. )
Consequence
DDX39B
ENST00000458640.5 5_prime_UTR
ENST00000458640.5 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.725
Publications
13 publications found
Genes affected
DDX39B (HGNC:13917): (DExD-box helicase 39B) This gene encodes a member of the DEAD box family of RNA-dependent ATPases that mediate ATP hydrolysis during pre-mRNA splicing. The encoded protein is an essential splicing factor required for association of U2 small nuclear ribonucleoprotein with pre-mRNA, and it also plays an important role in mRNA export from the nucleus to the cytoplasm. This gene belongs to a cluster of genes localized in the vicinity of the genes encoding tumor necrosis factor alpha and tumor necrosis factor beta. These genes are all within the human major histocompatibility complex class III region. Mutations in this gene may be associated with rheumatoid arthritis. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on both chromosomes 6 and 11. Read-through transcription also occurs between this gene and the upstream ATP6V1G2 (ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2) gene. [provided by RefSeq, Feb 2011]
ATP6V1G2-DDX39B (HGNC:41999): (ATP6V1G2-DDX39B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring ATP6V1G2 (ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2) and DDX39B (DEAD box polypeptide 39B) genes located in the major histocompatibility complex class III region of chromosome 6. The read-through transcript and is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0894 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DDX39B | NM_004640.7 | c.-408G>C | upstream_gene_variant | ENST00000396172.6 | NP_004631.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0753 AC: 10819AN: 143718Hom.: 451 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
10819
AN:
143718
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0597 AC: 31212AN: 523086Hom.: 1198 Cov.: 0 AF XY: 0.0569 AC XY: 15905AN XY: 279288 show subpopulations
GnomAD4 exome
AF:
AC:
31212
AN:
523086
Hom.:
Cov.:
0
AF XY:
AC XY:
15905
AN XY:
279288
show subpopulations
African (AFR)
AF:
AC:
1356
AN:
15064
American (AMR)
AF:
AC:
2171
AN:
33086
Ashkenazi Jewish (ASJ)
AF:
AC:
1187
AN:
19234
East Asian (EAS)
AF:
AC:
316
AN:
31392
South Asian (SAS)
AF:
AC:
1248
AN:
61034
European-Finnish (FIN)
AF:
AC:
1138
AN:
33100
Middle Eastern (MID)
AF:
AC:
156
AN:
3974
European-Non Finnish (NFE)
AF:
AC:
21852
AN:
297006
Other (OTH)
AF:
AC:
1788
AN:
29196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1515
3029
4544
6058
7573
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0752 AC: 10812AN: 143838Hom.: 449 Cov.: 33 AF XY: 0.0721 AC XY: 5081AN XY: 70474 show subpopulations
GnomAD4 genome
AF:
AC:
10812
AN:
143838
Hom.:
Cov.:
33
AF XY:
AC XY:
5081
AN XY:
70474
show subpopulations
African (AFR)
AF:
AC:
3765
AN:
41000
American (AMR)
AF:
AC:
1158
AN:
14400
Ashkenazi Jewish (ASJ)
AF:
AC:
225
AN:
3350
East Asian (EAS)
AF:
AC:
118
AN:
5162
South Asian (SAS)
AF:
AC:
79
AN:
4706
European-Finnish (FIN)
AF:
AC:
357
AN:
9790
Middle Eastern (MID)
AF:
AC:
14
AN:
288
European-Non Finnish (NFE)
AF:
AC:
4910
AN:
62328
Other (OTH)
AF:
AC:
158
AN:
1990
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
534
1068
1602
2136
2670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
73
AN:
3460
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.